Virtual Clinical Trials Market To Witness A Significant Growth Of USD 12.9 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh_7FCHoxn-JlRIPs0bCDHZaMgWvF5B-HykGgzuFZ7Ed0X0UjcclSVG6J5JhRtEIBLyzcQ6auFnDCf3BokVSgWgxCxOVvIjrgkfCzNb2qbghDqNCRQS7HVEKP_qibGw1foevtpo5x3QzLUgiGTh8l9bDOr6MthPerCS-eoyDAW_lWKeudnh4lsOqqIyJVs3/s320/Virtual%20Clinical%20Trials%20Market.png)
San Francisco, 7 Feb 2024: The Report Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease), By Phase, By Region, And Segment Forecasts, 2024 - 2030 The global virtual clinical trials market size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 5.7% from 2024 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth. There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials . Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have re